Genmab A/S Deferred Tax Relating To Items Charged Or Credited Directly To Equity
Genmab A/S (GNMSF) reported Deferred Tax Relating To Items Charged Or Credited Directly To Equity of DKK 66.00 million for the 12-month period ending 2018-12-31, per its 20-F filed 2020-03-30.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity · last filed 2020-03-30
| Period end | Deferred Tax Relating To Items Charged Or Credited Directly To Equity 12 month |
|---|---|
| 2018-12-31 | 66.00M DKK 20-F · filed 2020-03-30 |